不同他汀类药物对代谢综合征患者血清脂联素和瘦素的影响研究Effect of Atorvastain and Pravastatin on Serum Level of Adiponectin and Leptin in Patients with Metabolic Syndrome
陈劲松;陈瑞香;周燕飞;罗进才;彭兰芬;陈以初;
摘要(Abstract)：
目的探讨不同他汀类调脂药物对代谢综合征患者血清脂联素、瘦素的影响。方法选取明确诊断代谢综合征患者100例,随机分为两组,A组口服阿托伐他汀10mg/d,B组口服普伐他汀40mg/d,其他治疗相同。检测治疗前后血脂和脂联素及瘦素水平。结果两组治疗后血脂水平明显下降,两组无显著差异,而血清脂联素水平显著高于治疗前,瘦素水平低于治疗前,A组优于B组。结论两种他汀类调脂药物都可以明显升高代谢综合征患者的血清脂联素水平以及降低瘦素水平,阿托伐他汀优于普伐他汀。
关键词(KeyWords)： 代谢综合征;脂联素;瘦素;阿托伐他汀;普伐他汀
基金项目(Foundation): 东莞市科技局立项项目(2007105150095)
作者(Author): 陈劲松;陈瑞香;周燕飞;罗进才;彭兰芬;陈以初;
Email:
DOI:
参考文献(References)：
- 1 Alberti KG,Zimmet P,Shaw J.Metabolic syndrome a new worldwidedefinition.AConsensus Statement fromthe International Diabetes Feder-ation[J].Diabet Med,2006,23:469-480.
- 2 Alcberti KG,Zimmetp,Show J.IDF Epidemiology Task force Cousen-sus Group.The metabolic syndrome a new world wide definition[J].Lancet,2005,366:1059-1062.
- 3孙琦,扬国华.肿瘤坏死因子和瘦素在肥胖及胰岛素抵抗中的后果[J].中华内科杂志,2005,44:514-517.
- 4陆颖理,王雪芳,张丽.瘦素与代谢综合征及临床联系[J].实用糖尿病杂志,2007,3(1):8-10.
- 5刘军,陈影,刘芳,等.2型糖尿病家系非糖尿病一级亲属脂联素水平与胰岛素抵抗和动脉粥样硬化相关性的研究[J].中华内分泌代谢杂志,2004,20:215-216.
- 6 Sakamotok,Sakamoto T,Ogawa H,et al.The effect of 6 months oftreatment with pravastatin on serum adiponection concentrations in Japa-nese patients with Coronary artery disease and hypercholesterolemia;apilot study[J].Clin Ther,2006,28:1012-1021.
- 7 Sonmez A,Dogru T,TsaciI,et al.The effect of fluvastatin on plasmaadiponectin levels in dyslipidaemia[J].Clin Endocrinol,2006,64:567-572.
- 8 Chen Y,Ohmori K,Mizawa,et al.Differential impact of atorvastationvs pravastatin on progressive insulin resistance and left ventricular dias-tolic dysfunction in a rat model of typeⅡdiabetes[J].Circ J,2007,71:144-152.
文章评论(Comment)：
|
||||||||||||||||||
|
||||||||||||||||||